We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Duke Capital Limited | DUKE | London | Ordinary Share |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| 0.20 | 0.67% | 30.00 | 12:44:19 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 30.00 | 29.50 | 30.25 | 30.00 | 29.80 |
| Industry Sector |
|---|
| GENERAL FINANCIAL |
| Top Posts |
|---|
Posted at 15/11/2024 09:37 by cfro Now we know the real reason for the price drop. Not wholly unexpected though DUKE do this from time to time. It's what their business model is, so as investors we have to come to expect it. |
Posted at 15/11/2024 09:29 by riskvsreward What is the point of paying a high dividend that is taxed at up to 45% for high rate paying investors, and then ask them for more money back, in the process paying big fees to a lot of people. It is not exactly a high growth business to justify raising more money. Could be a sign of short of cash flow. |
Posted at 07/3/2024 17:03 by metis20 Very useful to see the Fairmed exit is likely to generate IRR in the high teens. That was not clear to me from yesterday's RNS.Fabrikat exit at IRR 36% looks to be their 2nd highest exit IRR - see slide 14 of |
Posted at 02/2/2024 16:05 by cfro Why would anybody pay for a ticket to hear a presentation from DUKE when they do loads of presentations to investors all the time free of charge Lol.. |
Posted at 02/2/2024 15:17 by melloteam Trading Update from Duke Royalty on MelloMondayJust to let shareholders and prospective investors know that Duke Royalty, Poolbeg Pharma and Time Finance will be presenting on the MelloMonday webinar on Monday 19th February 2024, starting at 5pm. There will be over 500 investors attending and these are very popular shows with company presentations, fund manager and investor interviews, and panel sessions. Tickets are still available and if you would like one at half price then enter the code MMTADVFN50. |
Posted at 15/12/2023 11:26 by weaverbeever An ad in the Times or investors chronicle or doing the podcast circuit would raise awareness |
Posted at 05/7/2023 08:29 by cfro It certainly needs sitting up and taking notice of. Investors champion knows what they are talking about.However, it's just worth keeping it simple. As long as DUKE pulls the money in at one end then it can pay out to shareholders at the other.. |
Posted at 01/6/2023 08:16 by cfro Great update. The monthly and quarterly cashflow is what we as investors should focus on... |
Posted at 05/4/2023 07:01 by carcosa BTG,I have spoken to the company and have always received a professional replies. Some things I have got right and some things I have got wrong. That is not to say I don't question their rationale or do my 'DYOR'. I have been invested since 2011 so am quite happy with returns to date. I had previously addressed your concern regarding company's results timescales in my second to last paragraph in my prior post. At a Duke level the business is relatively easy to understand but investors should also question the board, question assumptions, question risks. That is in some part the responsibility of investors. Should an investee company go bankrupt then retail investors should be prepared. i.e. not be entirely surprised (and recognise that Duke themselves have discussed this very point), consider the effect on Duke - whilst a 'blow' it's far from a death knell for Duke - although as with bank runs etc., investors will bail out questioning (rightly or wrongly) the quality of their investees. The question is why is the share price so low? My view is that it is being seen as a Venture Capital type company; which does provide a large potential upside. If I was so negative with Duke I would not be invested; but that does not preclude me from examining the negative side of the story instead of burying my head in the ground lol! |
Posted at 05/4/2023 06:01 by carcosa "so other than this Trimite company that is not paying its dues, our other partners are all in the black, right?"If you go through the accounts of those available in Companies House (see post #896) many of those companies are struggling and those that are not are more or less breaking even. There does not seem to be any outstandingly profitable companies in the visible portfolio. Many detractors have indicated that the terms of a Duke loan are very onerous and ask why would these companies not go through traditional lending facilities. Duke have addressed these concerns in the past and in practically all of their presentations. It's up to investors to determine the quality of those rebuttals. It is perhaps surprising Duke do not have profitable any high-tech companies in their portfolio. Given Duke claim they do a lot of due diligence, albeit via a third party, the companies do not appear to be of high quality and several depend on Duke to remain in business. Recent investments however eg New Path Fire and Security Ltd do seem to be a step up in quality. So perhaps after DUKE have made a land grab to get them started they are becoming less risk tolerant which may explain why so few deals have been made in the last year or so. Assuming that the realisable NAVs are lower than accounting standards (which is not uncommon) and that profitable company disposals are like a venture capital company's exit via an IPO. There are certainly significant differences, but overall, it's not too far off the mark. it would be reasonable for investors to view Duke as a venture capital company (especially given their high equity ownership to the extent they are the majority shareholder in Trimate). Perhaps that could explain why Duke trade well below NAV. Given companies' house have results that are relatively old for the companies they are to some extent reflecting businesses exiting the COVID era so maybe things are not so bad; but many of those businesses performed poorly prior to COVID. Fortunately investors have free access to Companies House and therefore can DYOR. |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
